Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

342 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Increased susceptibility of ras-transformed cells to phenylacetate is associated with inhibition of p21ras isoprenylation and phenotypic reversion.
Shack S, Chen LC, Miller AC, Danesi R, Samid D. Shack S, et al. Among authors: miller ac. Int J Cancer. 1995 Sep 27;63(1):124-9. doi: 10.1002/ijc.2910630122. Int J Cancer. 1995. PMID: 7558439
Increased radiation resistance in transformed and nontransformed cells with elevated ras proto-oncogene expression.
Samid D, Miller AC, Rimoldi D, Gafner J, Clark EP. Samid D, et al. Among authors: miller ac. Radiat Res. 1991 May;126(2):244-50. Radiat Res. 1991. PMID: 2023995
Observation of radiation-specific damage in human cells exposed to depleted uranium: dicentric frequency and neoplastic transformation as endpoints.
Miller AC, Xu J, Stewart M, Brooks K, Hodge S, Shi L, Page N, McClain D. Miller AC, et al. Radiat Prot Dosimetry. 2002;99(1-4):275-8. doi: 10.1093/oxfordjournals.rpd.a006783. Radiat Prot Dosimetry. 2002. PMID: 12194305
Neoplastic transformation of human osteoblast cells to the tumorigenic phenotype by heavy metal-tungsten alloy particles: induction of genotoxic effects.
Miller AC, Mog S, McKinney L, Luo L, Allen J, Xu J, Page N. Miller AC, et al. Carcinogenesis. 2001 Jan;22(1):115-25. doi: 10.1093/carcin/22.1.115. Carcinogenesis. 2001. PMID: 11159749
Transformation of human osteoblast cells to the tumorigenic phenotype by depleted uranium-uranyl chloride.
Miller AC, Blakely WF, Livengood D, Whittaker T, Xu J, Ejnik JW, Hamilton MM, Parlette E, John TS, Gerstenberg HM, Hsu H. Miller AC, et al. Environ Health Perspect. 1998 Aug;106(8):465-71. doi: 10.1289/ehp.98106465. Environ Health Perspect. 1998. PMID: 9681973 Free PMC article.
Tumor radiosensitization based on the use of inhibitors of the mevalonate pathway of cholesterol synthesis.
Miller AC, Samid D. Miller AC, et al. Adv Exp Med Biol. 1997;400B:825-30. Adv Exp Med Biol. 1997. PMID: 9547635 No abstract available.
Increased radioresistance of EJras-transformed human osteosarcoma cells and its modulation by lovastatin, an inhibitor of p21ras isoprenylation.
Miller AC, Kariko K, Myers CE, Clark EP, Samid D. Miller AC, et al. Int J Cancer. 1993 Jan 21;53(2):302-7. doi: 10.1002/ijc.2910530222. Int J Cancer. 1993. PMID: 8425769
Differences in radiation-induced micronuclei yields of human cells: influence of ras gene expression and protein localization.
Miller AC, Gafner J, Clark EP, Samid D. Miller AC, et al. Int J Radiat Biol. 1993 Nov;64(5):547-54. doi: 10.1080/09553009314551761. Int J Radiat Biol. 1993. PMID: 7902394
Tumor resistance to oxidative stress: association with ras oncogene expression and reversal by lovastatin, an inhibitor of p21ras isoprenylation.
Miller AC, Samid D. Miller AC, et al. Int J Cancer. 1995 Jan 17;60(2):249-54. doi: 10.1002/ijc.2910600220. Int J Cancer. 1995. PMID: 7829224
Transcriptional upregulation of TGF-alpha by phenylacetate and phenylbutyrate is associated with differentiation of human melanoma cells.
Liu L, Hudgins WR, Miller AC, Chen LC, Samid D. Liu L, et al. Among authors: miller ac. Cytokine. 1995 Jul;7(5):449-56. doi: 10.1006/cyto.1995.0061. Cytokine. 1995. PMID: 7578983
342 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback